KP496

Modify Date: 2024-01-22 18:37:34

KP496 Structure
KP496 structure
Common Name KP496
CAS Number 217799-03-6 Molecular Weight 692.27
Density N/A Boiling Point N/A
Molecular Formula C31H34ClN3O7S3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of KP496


KP496 is a selective, dual antagonist for Leukotriene D4 receptor and Thromboxane A2 receptor.

 Names

Name KP496

 KP496 Biological Activity

Description KP496 is a selective, dual antagonist for Leukotriene D4 receptor and Thromboxane A2 receptor.
Related Catalog
Target

LTD4

TXA2 Receptor

In Vivo KP496 significantly inhibits acute (day 7) and chronic (day 21) lung inflammation. KP496 attenuates the number of lymphocytes on day 7 and those of macrophages, neutrophils, and eosinophils on days 7 and 21. KP496 and prednisolone significantly suppress the increase of hydroxyl-L-proline content in the lung. Compare to respective vehicle control group, the inhibition ratio of KP496 and prednisolone for increase of hydroxyl-L-proline content is about 74 and 63%, respectively[1]. The KP496 (100 mg/head) group and prednisolone (10 mg/kg) group exhibit significant inhibition of numbers of infiltrating total cells, eosinophils, monocytes/macrophages, and lymphocytes compare with the control group. Infiltration of all types of cells except neutrophils is decreased in the KP496 (30m g/head) group, though not to significant extents[2].
Animal Admin Male mice (9 weeks old, 33 to 42g are used) BLM solution (15 mg/mL) is intravenously injected into mice (0.1 mL/10 g of body weight) on day 0. Mice are sacrificed on day 7 or 21. They are exposed to an aerosol of KP496 (KP-496) solution (0.5%) for 30 min using a pressure nebulizer 1 h before and 3 h after BLM-injection on day 0. From day 1 to the day before sacrificed, mice are exposed to KP496 (0.5%) for 30 min morning and evening[1].
References

[1]. Kurokawa S, et al. Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice. Pulm Pharmacol Ther. 2010 Oct;23(5):425-31.

[2]. Ishimura M, et al. Effects of KP-496, a novel dual antagonist for cysteinyl leukotriene receptor 1 and thromboxane A2 receptor, on Sephadex-induced airway inflammation in rats. Biol Pharm Bull. 2009 Jun;32(6):1057-61.

 Chemical & Physical Properties

Molecular Formula C31H34ClN3O7S3
Molecular Weight 692.27
Storage condition 2-8℃